PharmD Info

A forum for Indian Pharmacy Professionals

Important: Registered today to have the complete access on this forum --- Register Here
Pharmacy Education is an online discussion forum is a group open to any pharmacy students and graduates to update and share their knowledge related to their specializations.Eg: Study materials, Exam Questions, Case & Problem Based Learning Discussions.
Forum rules: Dear User, Kindly read our forum rules before you proceed with our PharmD Info, Your first 5 posts/topics requires moderator approval and this website is purely meant for educational and knowledge sharing purpose only so you should not make any topics/replies/messages which criticize, threaten or abuse any member, pharmacy governing bodies and organizations. Your post will be deleted automatically by our BB Pruning System if your topic is not viewed by members for more than 5 days. So, make sure that your topics and its related contents are unique and valuable. We expect you to be an active member of our forum to continue with your free membership.Kindly note that if a member received more than five warnings from moderator/members they will be blocked automatically by our Bulletin Board system.
  • User avatar
#2513
Dear All,
Anyone interested can access VigiAccess at http://www.vigiaccess.org/
To improve patient safety, increase transparency and encourage the reporting of adverse effects from medicinal products, the World Health Organization (WHO) launched VigiAccessTM on 17 April 2015.

VigiAccess is a new web application that will allow anyone to access information on reported cases of adverse events related to over 150 000 medicines and vaccines. More than ten million cases from over 120 countries are held in VigiBaseTM , the WHO database of suspected adverse reaction reports maintained by the Uppsala Monitoring Centre in Sweden.

This database allows you to browse and view data on suspected side-effects from various medicinal products (also known as suspected adverse drug reactions (“ADRs”)). All data contained herein is sourced from VigiBase®, the World Health Organization’s (the “WHO”) global database for ADRs, maintained by the Uppsala Monitoring Centre (the “UMC”).

“VigiAccess is a global public good,” said Marie-Paule Kieny, WHO Assistant Director General for Health Systems and Innovation. “By promoting open access and transparency, we hope that we will also promote medicine awareness and save lives.”
Admin liked this
Similar Topics
Topics Statistics Last post
2 Replies 
1371 Views
by Admin
19 Apr 2018, 14:07
Indian Pharm D graduates can open clinics?
by Admin  - 17 Dec 2017, 17:01  - In: Pharm D Topics
2 Replies 
2339 Views
by yamini krishna
04 Jul 2018, 17:08
0 Replies 
870 Views
by Admin
20 Dec 2016, 16:57
0 Replies 
858 Views
by Admin
15 Oct 2017, 11:10
FDA - Drug Safety Podcasts
by unbreakable  - 16 May 2018, 14:40  - In: Drug Safety Alerts
0 Replies 
418 Views
by unbreakable
16 May 2018, 14:40

Tags

Here is recently issued (December 2018) guidance -[…]

List of Pharmacovigilance Interview Questions and […]

Hello Everyone

Thanks for your appreciations . Keep doing your be[…]

Top Clinical Research Interview Questions Were Lis[…]

WELCOME TO OUR E-LEARN COURSE WORK MODULES